PRVB—Even after today’s pop in the AH session, the share price is down 49% from the high on 11/22/21 (the day PRVB issued the PR stating that the data to resubmit the BLA was in hand).
The 49% drop in a 2-month period where essentially nothing changed is an indication of how bad the biotech market is right now.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”